These delays are not just inconvenient—they are dangerous. For people with progressive diseases like MS, every missed day of ...

LMU researchers demonstrate that certain immune cells already play an important role in the early stages of multiple sclerosis ...

SetPoint has already reported positive topline results for the trial in a separate study in rheumatoid arthritis.

Every day, I see how unnecessary delays in treatment caused by cumbersome prior authorization barriers affect my patients.

Getting a moderate amount of healthy exercise can also help protect against cognitive decline, as does eating well and ...

Investment led by healthcare-focused institutional investor with participation from SymBiosis; founding investor Kensington Capital Holdings; ...

While there's currently no cure for multiple sclerosis, a lot of new treatment options have become available—many in just the ...

A new study shows that CD8-positive T cells play a significant role in the early stages of multiple sclerosis (MS).

Cognitive impairment is a recognized sequela of the demyelinating disorder multiple sclerosis (MS). Various studies have ...

Novartis reports strong Q2 2024 sales, with Kesimpta and Pluvicto showing significant growth. Learn more about NVSEF stock ...

The following is a summary of “Vascular Function in Multiple Sclerosis: Systematic Review with Meta-Analysis,” published in ...